Context� Novel therapies have improved the remission rate in chronic inflammatory disorders including juvenile idiopathic barthritis/b (JIA). Therefore, strategies of tapering therapy and reliable parameters for detecting subclinical inflammation have now become challenging questions. Objectives� To analyze whether longer methotrexate treatment during remission of JIA prevents flares after ...